Glomerular Filtration Rate

• 

  Subject Areas on Research

  • A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD. 
  • A computational model of epithelial solute and water transport along a human nephron. 
  • A controlled clinical trial of angiotensin-converting enzyme inhibition in type I diabetic nephropathy: study design and patient characteristics. The Collaborative Study Group. 
  • A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important? 
  • A role for leukotrienes in cyclosporine nephrotoxicity. 
  • A varying patient safety profile between black and nonblack adults with decreased estimated GFR. 
  • Abdominopelvic and lower extremity deep venous thrombosis: evaluation with contrast-enhanced MR venography with a blood-pool agent. 
  • Absence of tubuloglomerular feedback responses in AT1A receptor-deficient mice. 
  • Activation of Galpha q-coupled signaling pathways in glomerular podocytes promotes renal injury. 
  • Acute decline in renal function, inflammation, and cardiovascular risk after an acute coronary syndrome. 
  • Acute kidney injury after cardiac and non-cardiac surgery: are there more similarities than differences? 
  • Acute kidney injury and cardiovascular outcomes in acute severe hypertension. 
  • Acute kidney injury following cardiac surgery: role of perioperative blood pressure control. 
  • Acute kidney injury increases mortality after lung transplantation. 
  • Adherence to Healthy Dietary Patterns and Risk of CKD Progression and All-Cause Mortality: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study. 
  • Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium. 
  • Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF). 
  • Agalsidase-beta therapy for advanced Fabry disease: a randomized trial. 
  • Age, Race and Cardiovascular Outcomes in African American Veterans. 
  • Age-specific association of reduced estimated glomerular filtration rate and albuminuria with all-cause mortality. 
  • Age-specific associations of reduced estimated glomerular filtration rate with concurrent chronic kidney disease complications. 
  • Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial. 
  • Albuminuria and kidney function as prognostic marker of left ventricular mass among South Asians with hypertension. 
  • Albuminuria in chronic heart failure: prevalence and prognostic importance. 
  • Alemtuzumab induction and triple maintenance immunotherapy in kidney transplantation from donors after cardiac death. 
  • Allogeneic Mesenchymal Stem Cells for Treatment of AKI after Cardiac Surgery. 
  • Altered intragraft immune responses and improved renal function in MHC class II-deficient mouse kidney allografts. 
  • An Evaluation of Baseline Kidney Function in the REPRIEVE Trial of Pitavastatin in Human Immunodeficiency Virus. 
  • An instrumental variable approach finds no associated harm or benefit with early dialysis initiation in the United States. 
  • Angiotensin II Type 1 receptor antibodies are associated with inflammatory cytokines and poor clinical outcomes in pediatric kidney transplantation. 
  • Angiotensinogen gene null-mutant mice lack homeostatic regulation of glomerular filtration and tubular reabsorption. 
  • Anti-Leukocyte Function-Associated Antigen 1 Therapy in a Nonhuman Primate Renal Transplant Model of Costimulation Blockade-Resistant Rejection. 
  • Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease. 
  • Assessment of different threshold preoperative glomerular filtration rates as markers of outcomes in lung transplantation. 
  • Association between estimated glomerular filtration rate and clinical outcomes in patients with acute ischaemic stroke: results from China National Stroke Registry. 
  • Association between serum gamma-glutamyltransferase and chronic kidney disease among US adults. 
  • Association of Different Estimates of Renal Function With Cardiovascular Mortality and Bleeding in Atrial Fibrillation. 
  • Association of Fitness With Racial Differences in Chronic Kidney Disease. 
  • Association of Kidney Function With 30-Day and 1-Year Poststroke Mortality and Hospital Readmission. 
  • Association of Multimorbidity with Mortality and Healthcare Utilization in Chronic Kidney Disease. 
  • Association of Opioids and Nonsteroidal Anti-inflammatory Drugs With Outcomes in CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study. 
  • Association of Race With Mortality and Cardiovascular Events in a Large Cohort of US Veterans. 
  • Association of Reduced eGFR and Albuminuria with Serious Fall Injuries among Older Adults. 
  • Association of a cystatin C gene variant with cystatin C levels, CKD, and risk of incident cardiovascular disease and mortality. 
  • Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. 
  • Association of functional and structural social support with chronic kidney disease among African Americans: the Jackson Heart Study. 
  • Association of glomerular filtration rate with outcomes of acute stroke in type 2 diabetic patients: results from the China National Stroke Registry. 
  • Association of serum phosphorus level with anemia in kidney transplant recipients. 
  • Associations between retinal microvascular abnormalities and declining renal function in the elderly population: the Cardiovascular Health Study. 
  • Associations between worsening renal function and 30-day outcomes among Medicare beneficiaries hospitalized with heart failure. 
  • Belatacept Combined With Transient Calcineurin Inhibitor Therapy Prevents Rejection and Promotes Improved Long-Term Renal Allograft Function. 
  • Benefit of Ezetimibe Added to Simvastatin in Reduced Kidney Function. 
  • Bifurcation analysis of TGF-mediated oscillations in SNGFR. 
  • Bilateral native nephrectomy improves renal isograft function in rats. 
  • Bilateral native nephrectomy reduces systemic oxalate level after combined liver-kidney transplant: A case report. 
  • Biomarkers in atrial fibrillation: a clinical review. 
  • Biomarkers of Mineral and Bone Metabolism and 20-Year Risk of Hospitalization With Infection: The Atherosclerosis Risk in Communities Study. 
  • Blood pressure and chronic kidney disease progression in a multi-racial cohort: the Multi-Ethnic Study of Atherosclerosis. 
  • Body mass index and preclinical kidney disease in Indian adults aged 40 years and above without chronic kidney disease. 
  • Both chronic kidney disease and nocturnal blood pressure associate with strokes in the elderly. 
  • Brief Report: Kidney Dysfunction Does Not Contribute Significantly to Antiretroviral Therapy Modification in Treatment-Naive PLWH Receiving Initial ART. 
  • C-index is associated with functional outcomes after laparoscopic partial nephrectomy. 
  • CD20-positive infiltrates in renal allograft biopsies with acute cellular rejection are not associated with worse graft survival. 
  • CD57(+) CD4 T Cells Underlie Belatacept-Resistant Allograft Rejection. 
  • CKD progression and mortality among older patients with diabetes. 
  • CT volumetry is superior to nuclear renography for prediction of residual kidney function in living donors. 
  • Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney. 
  • Carboplatin pharmacokinetics in young children with brain tumors. 
  • Cardiorenal interactions: insights from the ESCAPE trial. 
  • Cardiovascular disease and chronic kidney disease: insights and an update. 
  • Central venous pressure after coronary artery bypass surgery: does it predict postoperative mortality or renal failure? 
  • Change in estimated glomerular filtration rate and fracture risk in the Action to Control Cardiovascular Risk in Diabetes Trial. 
  • Changes in Urinary Microbiome Populations Correlate in Kidney Transplants With Interstitial Fibrosis and Tubular Atrophy Documented in Early Surveillance Biopsies. 
  • Changing epidemiology of nephrotic syndrome in Nigerian children: A cross-sectional study. 
  • Chronic Kidney Disease and Antiretroviral Therapy in HIV-Positive Individuals: Recent Developments. 
  • Chronic effects of nitrendipine on renal hemodynamics and tubular transport. 
  • Chronic kidney disease after hematopoietic cell transplantation: a systematic review. 
  • Chronic kidney disease and bleeding complications after intravenous thrombolytic therapy for acute ischemic stroke. 
  • Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. 
  • Chronic kidney disease and intraocular pressure: the Singapore Malay Eye Study. 
  • Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial. 
  • Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease. 
  • Chronic kidney disease, cardiovascular disease and mortality: A prospective cohort study in a multi-ethnic Asian population. 
  • Chronic pain and analgesic use in CKD: implications for patient safety. 
  • Chronic rejection of mouse kidney allografts. 
  • Chronic thromboxane synthase inhibition with CGS 12970 in human cyclosporine nephrotoxicity. 
  • Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes. 
  • Circulating angiopoietin-2 as a biomarker in ANCA-associated vasculitis. 
  • Clinical Correlates and Prognostic Value of Proenkephalin in Acute and Chronic Heart Failure. 
  • Clinical Impact of Diabetes Mellitus on Outcomes After Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. 
  • Clinical and metabolomic risk factors associated with rapid renal function decline in sickle cell disease. 
  • Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. 
  • Clinical observation of patients with Fabry disease after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal). 
  • Clinical trial of focal segmental glomerulosclerosis in children and young adults. 
  • Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life. 
  • Clinical, pathologic, and functional outcomes after nephron-sparing surgery in patients with a solitary kidney: a multicenter experience. 
  • Clinically stable human renal allografts contain histological and RNA-based findings that correlate with deteriorating graft function. 
  • Cockcroft-Gault versus modification of diet in renal disease: importance of glomerular filtration rate formula for classification of chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. 
  • Combined impact of age and estimated glomerular filtration rate on in-hospital mortality after percutaneous coronary intervention for acute myocardial infarction (from the American College of Cardiology National Cardiovascular Data Registry). 
  • Community mobility among older adults with reduced kidney function: a study of life-space. 
  • Comparative Effectiveness of CRT-D Versus Defibrillator Alone in HF Patients With Moderate-to-Severe Chronic Kidney Disease. 
  • Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trial. 
  • Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD. 
  • Comparison of 2-Year Outcomes of Extended Criteria Cardiac Transplantation Versus Destination Left Ventricular Assist Device Therapy Using Continuous Flow. 
  • Comparison of Associations of Reduced Estimated Glomerular Filtration Rate With Stroke Outcomes Between Hypertension and No Hypertension. 
  • Comparison of bare-metal and drug-eluting stents in patients with chronic kidney disease (from the NHLBI Dynamic Registry). 
  • Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate. 
  • Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitus. 
  • Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. 
  • Competing Risks of Fracture and Death in Older Adults with Chronic Kidney Disease. 
  • Complete Chain of the First Global Kidney Exchange Transplant and 3-yr Follow-up 
  • Complete Remission in the Nephrotic Syndrome Study Network. 
  • Consideration of ICD-9 code-derived disease-specific safety indicators in CKD. 
  • Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure. 
  • Correction of anemia with epoetin alfa in chronic kidney disease. 
  • Creatinine measurement: state of the art in accuracy and interlaboratory harmonization. 
  • Creatinine versus cystatin C for renal function-based mortality prediction in an elderly cohort: The Northern Manhattan Study. 
  • Creatinine- versus cystatin C-based renal function assessment in the Northern Manhattan Study. 
  • Crosstransplantation of kidneys in normal and Hyp mice. Evidence that the Hyp mouse phenotype is unrelated to an intrinsic renal defect. 
  • Current evidence on treatment of patients with chronic systolic heart failure and renal insufficiency: practical considerations from published data. 
  • Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes study. 
  • Death and Dialysis After Transcatheter Aortic Valve Replacement: An Analysis of the STS/ACC TVT Registry. 
  • Deficiency of 5-lipoxygenase abolishes sex-related survival differences in MRL-lpr/lpr mice. 
  • Determining eligibility for lung transplantation: A nationwide assessment of the cutoff glomerular filtration rate. 
  • Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure). 
  • Disordered FGF23 and mineral metabolism in children with CKD. 
  • Distribution of survival times in a real-world cohort of older adults with chronic kidney disease: the median may not be the message. 
  • Diuretics and ultrafiltration in acute decompensated heart failure. 
  • Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort. 
  • Does renal function affect the efficacy or safety of a pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysis. 
  • Donor kidney volume measured by computed tomography is a strong predictor of recipient eGFR in living donor kidney transplantation. 
  • Dosing in neonates: special considerations in physiology and trial design. 
  • Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions. 
  • Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease. 
  • Effect of Age and Renal Function on Survival After Left Ventricular Assist Device Implantation. 
  • Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation. 
  • Effect of Genetic African Ancestry on eGFR and Kidney Disease. 
  • Effect of Sitagliptin on Kidney Function and Respective Cardiovascular Outcomes in Type 2 Diabetes: Outcomes From TECOS. 
  • Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. 
  • Effect of captopril on the release of the components of the renin-angiotensin system into plasma and lymph. 
  • Effect of cyclosporine on renal function in survivors of liver transplantation after 1 year. 
  • Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial. 
  • Effect of high-dose atorvastatin on renal function in subjects with stroke or transient ischemic attack in the SPARCL trial. 
  • Effect of pegloticase on renal function in patients with chronic kidney disease: a post hoc subgroup analysis of 2 randomized, placebo-controlled, phase 3 clinical trials. 
  • Effect of primary care physicians' use of estimated glomerular filtration rate on the timing of their subspecialty referral decisions. 
  • Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. 
  • Effect of renal function on antihypertensive drug safety and efficacy in children. 
  • Effect of sustained flow perturbations on stability and compensation of tubuloglomerular feedback. 
  • Effect of tubular inhomogeneities on filter properties of thick ascending limb of Henle's loop. 
  • Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial. 
  • Effects of Liraglutide on Worsening Renal Function Among Patients With Heart Failure With Reduced Ejection Fraction: Insights From the FIGHT Trial. 
  • Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial. 
  • Effects of Selonsertib in Patients with Diabetic Kidney Disease. 
  • Effects of converting enzyme inhibition with captopril on renal function in normal and ACTH treated sheep. 
  • Effects of exenatide and open-label SGLT2 inhibitor treatment, given in parallel or sequentially, on mortality and cardiovascular and renal outcomes in type 2 diabetes: insights from the EXSCEL trial. 
  • Effects of serelaxin in acute heart failure patients with renal impairment: results from RELAX-AHF. 
  • Effects of serum creatinine calibration on estimated renal function in african americans: the Jackson heart study. 
  • Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update. 
  • Effects of thromboxane synthase inhibition with CGS 13080 in human cyclosporine nephrotoxicity. 
  • Effects of two nonsteroidal anti-inflammatory drugs, indomethacin and oxaprozin, on the kidney. 
  • Effects on angiotensin-converting enzyme inhibition on renal hemodynamics in renal artery stenosis. 
  • Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial. 
  • Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study. 
  • Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality. 
  • Elevated serum leptin, adiponectin and leptin to adiponectin ratio is associated with chronic kidney disease in Asian adults. 
  • Embolic protection and platelet inhibition during renal artery stenting. 
  • Enalapril in infants with single ventricle: results of a multicenter randomized trial. 
  • Enhanced Renal Clearance in Patients With Hemorrhagic Stroke. 
  • Enhanced renal leukotriene production in murine lupus: role of lipoxygenase metabolites. 
  • Epidemiology of chronic kidney disease among older adults: a focus on the oldest old. 
  • Erythropoiesis-stimulating agents increase the risk of acute stroke in patients with chronic kidney disease. 
  • Estimated GFR and the Effect of Intensive Blood Pressure Lowering After Acute Intracerebral Hemorrhage. 
  • Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. 
  • Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome. 
  • Estimating kidney function in HIV-infected adults in Kenya: comparison to a direct measure of glomerular filtration rate by iohexol clearance. 
  • Estimation of GFR in South Asians: a study from the general population in Pakistan. 
  • Ethnic disparities in prevalence and impact of risk factors of chronic kidney disease. 
  • Ethnic variation in the impact of metabolic syndrome components and chronic kidney disease. 
  • Evaluation of renal function before and after percutaneous mitral valve repair. 
  • Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial. 
  • Evidence that renal prostaglandin and thromboxane production is stimulated in chronic cyclosporine nephrotoxicity. 
  • Expression of endothelial protein C receptor in cortical peritubular capillaries associates with a poor clinical response in lupus nephritis. 
  • FGF23 and Left Ventricular Hypertrophy in Children with CKD. 
  • FGF23: fashion or physiology? 
  • Factors Associated with Chronic Kidney Disease and Their Clinical Utility in Primary Care Clinics in a Multi-Ethnic Southeast Asian Population. 
  • Fanconi syndrome accompanied by renal function decline with tenofovir disoproxil fumarate: a prospective, case-control study of predictors and resolution in HIV-infected patients. 
  • Feedback-mediated dynamics in a model of coupled nephrons with compliant thick ascending limbs. 
  • Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial. 
  • Fetal dexamethasone exposure accelerates development of renal function: relationship to dose, cell differentiation and growth inhibition. 
  • Fibroblast Growth Factor 23 and Anemia in the Chronic Renal Insufficiency Cohort Study. 
  • Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease. 
  • Fibroblast Growth Factor 23 and Risk of CKD Progression in Children. 
  • Fibroblast Growth Factor 23, Mineral Metabolism, and Adiposity in Normal Kidney Function. 
  • Fibroblast growth factor 23 and incident CKD in type 2 diabetes. 
  • Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. 
  • Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. 
  • Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. 
  • Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD. 
  • Ficoll is not a rigid sphere. 
  • First-in-human experience with Aortix intraaortic pump. 
  • Fractal analysis of the retinal vasculature and chronic kidney disease. 
  • Functional Implications of Renal Tumor Enucleation Relative to Standard Partial Nephrectomy. 
  • GFR-Specific versus GFR-Agnostic Cutoffs for Parathyroid Hormone and Fibroblast Growth Factor-23 in Advanced Chronic Kidney Disease. 
  • Genetic association for renal traits among participants of African ancestry reveals new loci for renal function. 
  • Genetic control of blood pressure and the angiotensinogen locus. 
  • Genome-wide association and functional follow-up reveals new loci for kidney function. 
  • Genome-wide association study of kidney function decline in individuals of European descent. 
  • Geographic variation in CKD prevalence and ESRD incidence in the United States: results from the reasons for geographic and racial differences in stroke (REGARDS) study. 
  • Global Cardiovascular and Renal Outcomes of Reduced GFR. 
  • Global glomerulosclerosis with nephrotic syndrome; the clinical importance of age adjustment. 
  • Glomerular filtration rate estimated using creatinine, cystatin C or both markers and the risk of clinical events in HIV-infected individuals. 
  • Health Education and General Practitioner Training in Hypertension Management: Long-Term Effects on Kidney Function. 
  • Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats : possible role in renoprotection. 
  • Hemorrhagic Herpes Simplex Virus Type 1 Nephritis: An Unusual Cause of Acute Allograft Dysfunction. 
  • Heparin-dependent platelet factor 4 antibodies and the impact of renal function on clinical outcomes: a retrospective study in hospitalized patients. 
  • Hepcidin and disordered mineral metabolism in chronic kidney disease. 
  • High normal levels of albuminuria and risk of hypertension in Indo-Asian population. 
  • High-normal albuminuria and risk of heart failure in the community. 
  • Hospital readmissions following HLA-incompatible live donor kidney transplantation: A multi-center study. 
  • Hospitalizations among adults with chronic kidney disease in the United States: A cohort study. 
  • Hospitalized hemorrhagic stroke patients with renal insufficiency: clinical characteristics, care patterns, and outcomes. 
  • Hypertension and kidney disease in Asia. 
  • Hypertension, chronic kidney disease, and the development of cardiovascular risk: a joint primacy. 
  • Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies. 
  • Hyponatremia in congestive heart failure: implications for neurohumoral activation and responses to orthostasis. 
  • Imaging-guided radiofrequency ablation of cystic renal neoplasms. 
  • Impact of Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices on Posttransplantation Mortality. 
  • Impact of anemia on physical function and survival among patients with coronary artery disease. 
  • Impact of automated reporting of estimated glomerular filtration rate in the veterans health administration. 
  • Impact of chronic kidney disease on activities of daily living in community-dwelling older adults. 
  • Impact of donor and recipient age difference on long-term allograft survival after living donor renal transplantation: analysis of 478 cases. 
  • Impact of early versus deferred antiretroviral therapy on estimated glomerular filtration rate in HIV-positive individuals in the START trial. 
  • Impact of estimated GFR reporting on patients, clinicians, and health-care systems: a systematic review. 
  • Impact of glomerular filtration rate in colchicine toxicity. 
  • Impact of higher hemoglobin targets on blood pressure and clinical outcomes: a secondary analysis of CHOIR. 
  • Impact of recovery of renal function on long-term mortality after coronary artery bypass grafting. 
  • Impact of renal dysfunction on acute coronary syndrome evaluation in observation unit patients. 
  • Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. 
  • Impact of systemic vascular risk factors on the choriocapillaris using optical coherence tomography angiography in patients with systemic hypertension. 
  • Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials. 
  • Improving the clinical value of estimating glomerular filtration rate by reporting all values: a contrarian viewpoint. 
  • In reply to 'validating GFR estimating samples with clinical outcomes'. 
  • In vivo Modeling Implicates APOL1 in Nephropathy: Evidence for Dominant Negative Effects and Epistasis under Anemic Stress. 
  • Inaccuracy of the Schwartz formula in estimating glomerular filtration rate in Nigerian children. 
  • Incidence and Progression of Chronic Kidney Disease in Black and White Individuals with Type 2 Diabetes. 
  • Increased Burden of Vision Impairment and Eye Diseases in Persons with Chronic Kidney Disease - A Population-Based Study. 
  • Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype. 
  • Increasing use of vitamin D supplementation in the chronic renal insufficiency cohort study. 
  • Influence of Kidney Function on Blood Pressure Response to Lifestyle Modifications: Secondary Analysis From the Exercise and Nutritional Interventions for Cardiovascular Health (ENCORE) Trial. 
  • Influence of creatinine versus glomerular filtration rate on non-steroidal anti-inflammatory drug prescriptions in chronic kidney disease. 
  • Influence of genetic background on albuminuria and kidney injury in Ins2(+/C96Y) (Akita) mice. 
  • Influence of renal function on the use of guideline-recommended therapies for patients with heart failure. 
  • Instantaneous and steady-state gains in the tubuloglomerular feedback system. 
  • Integration of genome-wide association studies with biological knowledge identifies six novel genes related to kidney function. 
  • Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects. 
  • International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design. 
  • Interruption of antiretroviral therapy is associated with increased plasma cystatin C. 
  • Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis. 
  • Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies. 
  • Invited commentary. 
  • Invited commentary. 
  • Is plasma renin activity associated with worse outcomes in acute heart failure? A secondary analysis from the BLAST-AHF trial. 
  • Is renal function associated with early age-related macular degeneration? 
  • Is the height/plasma creatinine formula of Schwartz useful as a screening test in detecting Nigeria children with low GFR? 
  • Is there a clear threshold for fasting plasma glucose that differentiates between those with and without neuropathy and chronic kidney disease?: the Singapore Prospective Study Program. 
  • Is there something better than the best marker of kidney function? 
  • Ischemic nephropathy and concomitant aortic disease: a ten-year experience. 
  • Kidney biopsy findings in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study. 
  • Kidney disease in antiretroviral-naïve HIV-positive adults with high CD4 counts: prevalence and predictors of kidney disease at enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. 
  • Laboratory blood tests useful in monitoring renal function in neonates. 
  • Laparoscopic anatrophic nephrolithotomy: developments of the technique in the era of minimally invasive surgery. 
  • Leukotrienes in renal transplant rejection in rats. Distinct roles for leukotriene B4 and peptidoleukotrienes in the pathogenesis of allograft injury. 
  • Level and determinants of kidney function in a South Asian population in Pakistan. 
  • Limit-cycle oscillations and tubuloglomerular feedback regulation of distal sodium delivery. 
  • Limited health literacy is associated with low glomerular filtration in the Chronic Renal Insufficiency Cohort (CRIC) study. 
  • Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA. 
  • Long-Term Blood Pressure Variability, New-Onset Diabetes Mellitus, and New-Onset Chronic Kidney Disease in the Japanese General Population. 
  • Long-term exposure to ambient air pollution and renal function in African Americans: the Jackson Heart Study. 
  • Long-term outcomes of medicare beneficiaries with worsening renal function during hospitalization for heart failure. 
  • Long-term survival following kidney transplantation in previous lung transplant recipients-An analysis of the unos registry. 
  • Low use of routine medical care among African Americans with high CKD risk: the Jackson Heart Study. 
  • Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. 
  • Lower urinary connective tissue growth factor levels and incident CKD stage 3 in the general population. 
  • Lymphocyte depletion and risk of acute rejection in renal transplant recipients at increased risk for delayed graft function. 
  • Management of postoperative atrial fibrillation and subsequent outcomes in contemporary patients undergoing cardiac surgery: insights from the Society of Thoracic Surgeons CAPS-Care Atrial Fibrillation Registry. 
  • Markers of Renal Function in Older Adults Completing a Higher Protein Obesity Intervention and One Year Later: Findings from the MEASUR-UP Trial. 
  • Meta-analysis identifies multiple loci associated with kidney function-related traits in east Asian populations. 
  • Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study. 
  • MicroRNAs relate to early worsening of renal function in patients with acute heart failure. 
  • Microalbuminuria predicts overt proteinuria among patients with HIV infection. 
  • Microvascular Disease After Renal Transplantation. 
  • Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial. 
  • Mineral metabolites and CKD progression in African Americans. 
  • Modifiers of Plasma 25-Hydroxyvitamin D and Chronic Kidney Disease Outcomes in Black Americans: The Jackson Heart Study. 
  • Morphometry Predicts Early GFR Change in Primary Proteinuric Glomerulopathies: A Longitudinal Cohort Study Using Generalized Estimating Equations. 
  • Mortality after myocardial infarction: the role of renal function and systolic and diastolic functions of the left ventricle. 
  • Mortality, kidney disease and cardiac procedures following acute coronary syndrome. 
  • Net endogenous acid production is associated with a faster decline in GFR in African Americans. 
  • Nondepressive Psychosocial Factors and CKD Outcomes in Black Americans. 
  • Nondisease-specific problems and all-cause mortality among older adults with CKD: the REGARDS Study. 
  • Nontraditional sites for vascular anastomoses to enable kidney transplantation in patients with major systemic venous thromboses. 
  • Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF. 
  • Normal function and lack of fibronectin accumulation in kidneys of Clara cell secretory protein/uteroglobin deficient mice. 
  • Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study. 
  • Off-pump versus on-pump coronary artery bypass grafting outcomes stratified by preoperative renal function. 
  • Outcomes and worsening renal function in patients hospitalized with heart failure with preserved ejection fraction. 
  • Parathyroid hormone independently predicts fracture, vascular events, and death in patients with stage 3 and 4 chronic kidney disease. 
  • Patterns of NSAIDs Use and Their Association with Other Analgesic Use in CKD. 
  • Patterns of care quality and prognosis among hospitalized ischemic stroke patients with chronic kidney disease. 
  • Pegunigalsidase alfa, a novel PEGylated enzyme replacement therapy for Fabry disease, provides sustained plasma concentrations and favorable pharmacodynamics: A 1-year Phase 1/2 clinical trial. 
  • Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical Simulation. 
  • Performance of Indexed and Nonindexed Estimated GFR. 
  • Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals. 
  • Perioperative renal dysfunction and cardiovascular anesthesia: concerns and controversies. 
  • Persistent high serum bicarbonate and the risk of heart failure in patients with chronic kidney disease (CKD): A report from the Chronic Renal Insufficiency Cohort (CRIC) study. 
  • Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study. 
  • Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcome. 
  • Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot Study. 
  • Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy. 
  • Population-based screening for CKD. 
  • Postdepletion Lymphocyte Reconstitution During Belatacept and Rapamycin Treatment in Kidney Transplant Recipients. 
  • Potential kidney toxicity from the antiviral drug tenofovir: new indications, new formulations, and a new prodrug. 
  • Predictors of low estimated glomerular filtration rate after living kidney donation in a Southeast Asian population from Singapore. 
  • Predictors of mortality in patients with chronic kidney disease and an implantable defibrillator: an EPGEN substudy. 
  • Predictors of target organ damage in hypertensive blacks and whites. 
  • Preoperative Renal Insufficiency: Underreporting and Association With Readmission and Major Postoperative Morbidity in an Academic Medical Center. 
  • Presurgical serum cystatin C and risk of acute kidney injury after cardiac surgery. 
  • Prevalence and Outcomes of Left-Sided Valvular Heart Disease Associated With Chronic Kidney Disease. 
  • Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease. 
  • Prevalence of apparent treatment-resistant hypertension among individuals with CKD. 
  • Prevalence of chronic kidney disease in China. 
  • Prevalence of kidney disease in HIV-infected and uninfected Rwandan women. 
  • Prevalence of reduced estimated glomerular filtration rate among the oldest old from 1988-1994 through 2005-2010. 
  • Prevalence, trends and functional impairment associated with reduced estimated glomerular filtration rate and albuminuria among the oldest-old U.S. adults. 
  • Preventing renal dysfunction in patients with hypertension: clinical implications from the early AASK Trial results. 
  • Prognostic value of troponins in patients with non-ST-segment elevation acute coronary syndromes and chronic kidney disease. 
  • Progressive glomerular toxicity of ifosfamide in children. 
  • Prolonged Correction of Serum Phosphorus in Adults With X-Linked Hypophosphatemia Using Monthly Doses of KRN23. 
  • Prolonged survival with a remnant kidney. 
  • Pulmonary Hypertension Is Associated With a Higher Risk of Heart Failure Hospitalization and Mortality in Patients With Chronic Kidney Disease: The Jackson Heart Study. 
  • Racial Differences in the Effectiveness of a Multifactorial Telehealth Intervention to Slow Diabetic Kidney Disease. 
  • Random forest for prediction of contrast-induced nephropathy following coronary angiography. 
  • Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia. 
  • Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk. 
  • Recognition of CKD after the introduction of automated reporting of estimated GFR in the Veterans Health Administration. 
  • Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study. 
  • Reduction in body weight but worsening renal function with late ultrafiltration for treatment of acute decompensated heart failure. 
  • Reduction of Cardiovascular Risk and Improved Estimated Glomerular Filtration Rate by SGLT2 Inhibitors, Including Dapagliflozin, Is Consistent Across the Class: An Analysis of the Placebo Arm of EXSCEL. 
  • Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. 
  • Relation of Baseline Renal Dysfunction With Outcomes in Patients Undergoing Popliteal and Infrapopliteal Percutaneous Peripheral Arterial Interventions. 
  • Relation of serum uric acid levels and outcomes among patients hospitalized for worsening heart failure with reduced ejection fraction (from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan trial). 
  • Relationship Among Viremia/Viral Infection, Alloimmunity, and Nutritional Parameters in the First Year After Pediatric Kidney Transplantation. 
  • Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: results from SYNERGY. 
  • Relationship between stage of kidney disease and incident heart failure in older adults. 
  • Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium. 
  • Relative contribution of vasopressin and angiotensin II to the altered renal microcirculatory dynamics in two-kidney Goldblatt hypertension. 
  • Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar. 
  • Renal Angina Is a Sensitive, but Nonspecific Identifier of Postcardiac Surgery Acute Kidney Injury. 
  • Renal Dysfunction Is Associated With Poststroke Discharge Disposition and In-Hospital Mortality: Findings From Get With The Guidelines-Stroke. 
  • Renal Dysfunction and In-Hospital Outcomes in Patients With Acute Ischemic Stroke After Intravenous Thrombolytic Therapy. 
  • Renal Function and Exercise Training in AmbulatoryHeart Failure Patients With a Reduced Ejection Fraction. 
  • Renal Outcomes in Patients Bridged to Heart Transplant With a Left Ventricular Assist Device. 
  • Renal Recovery Years After Initial Diagnosis of Hemolytic Uremic Syndrome. 
  • Renal autotransplants in sheep: investigation of renal function and renovascular hypertension. 
  • Renal dysfunction in allogeneic hematopoietic cell transplantation. 
  • Renal effects of angiotensin-converting enzyme inhibition in cardiac failure. 
  • Renal failure in patients with ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention: Predictors, clinical and angiographic features, and outcomes. 
  • Renal function after low central venous pressure-assisted liver resection: assessment of 2116 cases. 
  • Renal function and risk stratification of diabetic and nondiabetic patients undergoing evaluation for coronary artery disease. 
  • Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study. 
  • Renal function in the AT1A receptor knockout mouse during normal and volume-expanded conditions. 
  • Renal function outcomes for multifocal renal neoplasms managed by radiofrequency ablation. 
  • Renal hemodynamic and tubular transport effects of nitrendipine. 
  • Renal outcomes following left renal vein harvest for venous reconstruction during pancreas and liver surgery. 
  • Renal response following perioperative ketorolac analgesia in living kidney donation. 
  • Renal response to captopril in severe heart failure: role of furosemide in natriuresis and reversal of hyponatremia. 
  • Renal responses during a dry saturation dive to 450 msw. 
  • Renin-angiotensin system inhibition in advanced chronic kidney disease: how low can the kidney function go? 
  • Renovascular disease in children and adolescents. 
  • Reperfusion strategy and mortality in ST-elevation myocardial infarction among patients with and without impaired renal function. 
  • Reporting of estimated GFR in the primary care clinic. 
  • Retinal arteriolar narrowing and subsequent development of CKD Stage 3: the Multi-Ethnic Study of Atherosclerosis (MESA). 
  • Retinal microvascular caliber and chronic kidney disease in an Asian population. 
  • Reversibility of Glomerular Renal Function Decline in HIV-Uninfected Men and Women Discontinuing Emtricitabine-Tenofovir Disoproxil Fumarate Pre-Exposure Prophylaxis. 
  • Right-Sided Cardiac Dysfunction in Heart Failure With Preserved Ejection Fraction and Worsening Renal Function. 
  • Risk Analysis and Outcomes of Postoperative Renal Failure After Aortic Valve Surgery in the United States. 
  • Risk Factors for Heart Failure in Patients With Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study. 
  • Risk factors for reduced glomerular filtration rate in a Nicaraguan community affected by Mesoamerican nephropathy. 
  • Risk for cardiovascular outcomes among subjects with atherosclerotic cardiovascular disease and greater-than-normal estimated glomerular filtration rate. 
  • Role of platelet activating factor in kidney transplant rejection in the rat. 
  • S-Nitrosohemoglobin Levels and Patient Outcome After Transfusion During Pediatric Bypass Surgery. 
  • SOS2 and ACP1 Loci Identified through Large-Scale Exome Chip Analysis Regulate Kidney Development and Function. 
  • Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE Trial. 
  • Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: a report from the linked CathPCI Registry-CMS claims database. 
  • Safety events in kidney transplant recipients: results from the folic Acid for vascular outcome reduction in transplant trial. 
  • Safety of low-dose radiocontrast for interventional AV fistula salvage in stage 4 chronic kidney disease patients. 
  • Screening for chronic kidney disease. 
  • Selective Targeting of High-Affinity LFA-1 Does Not Augment Costimulation Blockade in a Nonhuman Primate Renal Transplantation Model. 
  • Self-reported Medication Adherence and Adverse Patient Safety Events in CKD. 
  • Self-reported depression in psoriasis is associated with subclinical vascular diseases. 
  • Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study. 
  • Serum creatinine as marker of kidney function in South Asians: a study of reduced GFR in adults in Pakistan. 
  • Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment. 
  • Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiative. 
  • Significance of hemolysis on extracorporeal life support after cardiac surgery in children. 
  • Simplified end stage renal failure risk prediction model for the low-risk general population with chronic kidney disease. 
  • Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trial. 
  • Spironolactone in Acute Heart Failure Patients With Renal Dysfunction and Risk Factors for Diuretic Resistance: From the ATHENA-HF Trial. 
  • Splenic Irradiation for the Treatment of Severe Antibody-Mediated Rejection. 
  • Striking a Balance in Simultaneous Heart Kidney Transplant: Optimizing Outcomes for All Wait-Listed Patients. 
  • Structural changes in the retinal microvasculature and renal function. 
  • Surgical management of bilateral synchronous kidney tumors: functional and oncological outcomes. 
  • Survival after primary prevention implantable cardioverter-defibrillator placement among patients with chronic kidney disease. 
  • Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. 
  • Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients. 
  • Synergistic effect of chronic kidney disease and high circulatory norepinephrine level on stroke risk in Japanese hypertensive patients. 
  • Systemic Kidney Transplant Inequities for Black Individuals: Examining the Contribution of Racialized Kidney Function Estimating Equations. 
  • Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study. 
  • Tacrolimus dose requirements in African-American and Caucasian kidney transplant recipients on mycophenolate and prednisone. 
  • Targeting Fall Risk in CKD. 
  • Targeting proximal tubule mitochondrial dysfunction attenuates the renal disease of methylmalonic acidemia. 
  • Temporal Trends in Utilization of Cardiac Therapies and Outcomes for Myocardial Infarction by Degree of Chronic Kidney Disease: A Report From the NCDR Chest Pain-MI Registry. 
  • The Association of Kidney Function and Albuminuria With the Risk and Outcomes of Syncope: A Population-Based Cohort Study. 
  • The CKD-EPI equation and MDRD study equation find similar prevalence of chronic kidney disease in Asian populations. 
  • The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarction. 
  • The Chronic Kidney Disease Epidemiology Collaboration (CKDEPI) equation best characterizes kidney function in patients being considered for lung transplantation. 
  • The Impact of Renal Impairment on Short-term Morbidity Risk Following Lumbar Spine Surgeries. 
  • The Incremental Cost of Incompatible Living Donor Kidney Transplantation: A National Cohort Analysis. 
  • The Relationship of Quantitative Retinal Capillary Network to Kidney Function in Type 2 Diabetes. 
  • The analytical change in plasma creatinine that constitutes a biologic/physiologic change. 
  • The association between pre-operative variables, including blood pressure, and postoperative kidney function. 
  • The effect of phosphate infusions upon renal phosphate clearance in man: evidence for tubular phosphate secretion. 
  • The effect of renal dysfunction on short-term outcomes after lumbar fusion. 
  • The effects of surgery and acute rejection on glomerular hemodynamics in the transplanted rat kidney. 
  • The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. 
  • The impact of renal function on outcomes of bariatric surgery. 
  • The microvasculature in chronic kidney disease. 
  • The natural history of renal function following orthotopic heart transplant. 
  • The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension. 
  • The role of carrier size in the pharmacodynamics of antisense and siRNA oligonucleotides. 
  • The significance of elevated troponin T in patients with nondialysis-dependent renal insufficiency: a validation with coronary angiography. 
  • Thromboxane receptor blockade improves cyclosporine nephrotoxicity in rats. 
  • Thromboxane receptor signalling in renal ischemia reperfusion injury. 
  • Timing of commencement of maintenance dialysis and mortality in young and older adults in Singapore. 
  • Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker. 
  • Trajectories of Changes in Renal Function in Patients with Acute Heart Failure. 
  • Trefoil factor 3 predicts incident chronic kidney disease: a case-control study nested within the Atherosclerosis Risk in Communities (ARIC) study. 
  • Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients. 
  • Tumor location does not affect long-term renal function after partial nephrectomy. 
  • Ultrastructural Characterization of Proteinuric Patients Predicts Clinical Outcomes. 
  • Urinary Exosomes and Exosomal CCL2 mRNA as Biomarkers of Active Histologic Injury in IgA Nephropathy. 
  • Urinary cystatin C and acute kidney injury after cardiac surgery. 
  • Urine Biomarkers and Perioperative Acute Kidney Injury: The Impact of Preoperative Estimated GFR. 
  • Urine NGAL as a biomarker of kidney damage after on- and off-pump coronary artery bypass graft surgery: a prospective pilot study. 
  • Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression. 
  • Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis. 
  • Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry. 
  • Use of glomerular filtration rate estimating equations for drug dosing in HIV-positive patients. 
  • Validated contemporary risk model of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the National Cardiovascular Data Registry Cath-PCI Registry. 
  • Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia. 
  • Variation in use of nephron-sparing surgery among children with renal tumors. 
  • Variation of serum creatinine, cystatin C, and creatinine clearance tests in persons with normal renal function. 
  • Will a new tenofovir prodrug for the treatment of HIV reduce the risk of nephrotoxicity? 
  • Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury. 
  • Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme. 
• 

  Keywords of People

  • Barker, Piers Christopher Andrew, Professor of Pediatrics, Pediatrics, Cardiology
  • Hogan, Brigid L. M., George Barth Geller Distinguished Professor for Research in Molecular Biology, Cell Biology
  • Mentz, Robert John, Associate Professor of Medicine, Medicine, Cardiology
  • Middleton, John Paul, Professor of Medicine, Medicine, Nephrology
  • Milano, Carmelo Alessio, Professor of Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • O'Connor, Christopher Michael, Richard Sean Stack, M.D. Distinguished Professor, Medicine, Clinical Pharmacology
  • Patel, Uptal Dinesh, Adjunct Professor in the Department of Medicine, Medicine, Nephrology